Cardiovascular Disease Biomarkers and Mediation of Hormone Therapy Effects
Cardiovascular Disease Biomarkers and Mediation of Hormone Therapy Effects
批准号:
8309334
负责人:
Ross L Prentice
金额:
$13.2万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2014-07-31
关键词:
AffectBinding ProteinsBiological AssayBiological MarkersBlood ProteinsBlood specimenCardiovascular DiseasesCohort StudiesComplement Factor DCoronary heart diseaseData AnalysesDiagnosisDiseaseEnrollmentEnzyme-Linked Immunosorbent AssayEstrogensHemopexinHormone replacement therapyIGFBP2 geneIGFBP6 geneIncidenceInflammationInsulinInsulin-Like Growth Factor IIInsulin-Like Growth-Factor Binding Protein 1InterventionLipidsMass Spectrum AnalysisMeasurementMeasuresMediatingMediationMediator of activation proteinOrosomucoidPhasePlasmaPlasma ProteinsPostmenopauseProbabilityProgestinsProteinsProteomeProteomicsRandomizedResearchRiskRisk FactorsRisk MarkerSamplingSpecimenStatistical MethodsStrokeThrombosisThrombospondin 1ValidationVariantWomanWomen&aposs HealthWorkbasebeta-2 Microglobulincardiovascular disorder riskcase controlcohortdisorder riskexperienceglutathione peroxidasehormone therapyinsightnovel
中文摘要
描述(由申请人提供):将对妇女健康倡议绝经后激素治疗试验中患者和对照的基线血浆样本应用酶联免疫吸附分析,对与冠心病和中风风险有关的新型血浆蛋白进行验证性分析。候选蛋白质在最近深入的蛋白质组发现研究中排名很高。对于冠心病,它们是α-1-酸性糖蛋白1、凝血酶反应蛋白1、补体因子D前蛋白、谷胱甘肽过氧化物酶3和胰岛素样结合蛋白1(IGFBP1)。对于中风,候选生物标志物是IGFBP2、IGFBP6、胰岛素样生长因子2、血凝素和β2微球蛋白。样本分析将对349例冠心病患者和1:1匹配的对照组进行,对326例中风患者和匹配的对照组进行分析。数据分析将控制传统的心血管疾病危险因素,以及炎症、血栓形成和血脂的现有生物标志物。在激素治疗试验登记的第一年后发展为冠心病或中风的女性和她们的匹配对照组,也将在使用相同的蛋白质组平台的发现工作中,在一年的血液样本中评估被发现受雌激素单独或受雌激素和孕激素影响的这些蛋白质的子集的血浆浓度。将对基线和1年的蛋白质浓度进行联合分析,以评估这些蛋白质浓度与治疗相关的变化在多大程度上可以中介激素治疗对冠心病和中风的影响。这些分析将纳入对生物标志物测量误差的新修正。该项目很有可能确认一些新的冠心病和中风风险的生物标志物,并为观察到的激素治疗对这些疾病的影响提供更多的洞察力。
英文摘要
DESCRIPTION (provided by applicant): Confirmatory analyses of novel plasma protein associations with the risk of coronary heart disease and stroke will be carried out by applying enzyme-linked immunosorbent assays to baseline plasma specimens from cases and controls in the Women's Health Initiative postmenopausal hormone therapy trials. Candidate proteins were highly ranked in recent in-depth proteomic discovery research. For CHD these are alpha-1-acid glycoprotein 1, thrombospondin 1, complement factor D preprotein, glutathione peroxidase 3, and insulin-like binding protein 1 (IGFBP1). For stroke the candidate biomarkers are IGFBP2, IGFBP6, insulin-like growth factor 2, hemopexin, and beta 2 microglobulin. Specimen analyses will be carried out for 349 CHD cases and for 1-1 matched controls, and for 326 stroke cases and matched controls. Data analyses will control for traditional cardiovascular disease risk factors, and for available biomarkers of inflammation, thrombosis, and lipids. Women developing CHD or stroke following their first year of hormone therapy trial enrollment, and their matched controls, will also have plasma concentrations assessed in 1-year blood specimens for the subset of these proteins found to be affected by estrogen-alone or by estrogen plus progestin in discovery work using the same proteomic platform. The baseline and 1-year protein concentrations will be jointly analyzed to assess the extent to which treatment-related changes in these protein concentrations can mediate hormone therapy effects on CHD and stroke. These analyses will incorporate a novel correction for biomarker measurement error. The project has a high probability of confirming some new biomarkers of CHD and stroke risk, and for providing additional insight into observed hormone therapy effects on these diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Statistical Methods for Multivariate Failure Time Data
-
批准号:9206644
-
项目类别:
-
资助金额:$16.46万
-
财政年份:2016
-
负责人:Ross L Prentice
-
依托单位:
Statistical Methods for Multivariate Failure Time Data
-
批准号:9403190
-
项目类别:
-
资助金额:$16.46万
-
财政年份:2016
-
负责人:Ross L Prentice
-
依托单位:
Cardiovascular Disease Biomarkers and Mediation of Hormone Therapy Effects
-
批准号:8166022
-
项目类别:
-
资助金额:$35.2万
-
财政年份:2011
-
负责人:Ross L Prentice
-
依托单位:
Administrative Core
-
批准号:7152317
-
项目类别:
-
资助金额:$2.07万
-
财政年份:2006
-
负责人:Ross L Prentice
-
依托单位:
Nutrition and Physical Activity Assessment Study (NPAAS)
-
批准号:7259454
-
项目类别:
-
资助金额:$74.71万
-
财政年份:2006
-
负责人:Ross L Prentice
-
依托单位:
Nutrition and Physical Activity Assessment Study (NPAAS)
-
批准号:7455869
-
项目类别:
-
资助金额:$68.86万
-
财政年份:2006
-
负责人:Ross L Prentice
-
依托单位:
Chronic Disease Population Research Issues and Strategies
-
批准号:7153262
-
项目类别:
-
资助金额:$10.64万
-
财政年份:2006
-
负责人:Ross L Prentice
-
依托单位:
Nutrition and Physical Activity Assessment Study (NPAAS)
-
批准号:7149737
-
项目类别:
-
资助金额:$90.53万
-
财政年份:2006
-
负责人:Ross L Prentice
-
依托单位:
STATISTICAL METHODS FOR DISEASE PREVENTION TRIALS
-
批准号:6300380
-
项目类别:
-
资助金额:$18.91万
-
财政年份:2000
-
负责人:Ross L Prentice
-
依托单位:
STATISTICAL METHODS FOR DISEASE PREVENTION TRIALS
-
批准号:6102661
-
项目类别:
-
资助金额:$18.91万
-
财政年份:1999
-
负责人:Ross L Prentice
-
依托单位:
STATISTICAL METHODS FOR DISEASE PREVENTION TRIALS
-
批准号:6269468
-
项目类别:
-
资助金额:$19.05万
-
财政年份:1998
-
负责人:Ross L Prentice
-
依托单位:
Statistical Methods for Medical Studies
-
批准号:7130130
-
项目类别:
-
资助金额:$49.81万
-
财政年份:1997
-
负责人:Ross L Prentice
-
依托单位:
Statistical Methods for Medical Studies
-
批准号:7472475
-
项目类别:
-
资助金额:$58.25万
-
财政年份:1997
-
负责人:Ross L Prentice
-
依托单位:
Statistical Methods for Medical Studies
-
批准号:7647440
-
项目类别:
-
资助金额:$60.61万
-
财政年份:1997
-
负责人:Ross L Prentice
-
依托单位:
Statistical Methods for Medical Studies
-
批准号:7255476
-
项目类别:
-
资助金额:$60.72万
-
财政年份:1997
-
负责人:Ross L Prentice
-
依托单位:
Statistical Methods for Medical Studies
-
批准号:8534546
-
项目类别:
-
资助金额:$60.5万
-
财政年份:1997
-
负责人:Ross L Prentice
-
依托单位:
Statistical Methods for Medical Studies
-
批准号:8692661
-
项目类别:
-
资助金额:$62.17万
-
财政年份:1997
-
负责人:Ross L Prentice
-
依托单位:
Statistical Methods for Medical Studies
-
批准号:8302266
-
项目类别:
-
资助金额:$64.61万
-
财政年份:1997
-
负责人:Ross L Prentice
-
依托单位:
Statistical Methods for Medical Studies
-
批准号:8152376
-
项目类别:
-
资助金额:$66.74万
-
财政年份:1997
-
负责人:Ross L Prentice
-
依托单位:
CORE--EPIDEMIOLOGY AND BIOSTATISTICS
-
批准号:6236217
-
项目类别:
-
资助金额:$34.82万
-
财政年份:1997
-
负责人:Ross L Prentice
-
依托单位:
海外基金